Listen for Questions About Aduhelm for Alzheimer's Disease

August 2021

You'll hear controversy about Aduhelm (aducanumab), the first new med for Alzheimer's disease in almost 20 years.

It's different than other Alzheimer's meds (donepezil, etc).

Aduhelm is a monoclonal antibody given as an IV infusion every 4 weeks...and it's intended to target and affect the underlying disease.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Pharmacy Technicians Prepare for New Roles and Career Opportunities
Obesity & Weight Loss Watch for Wegovy, a New Injectable Weight Loss Med
Med Administration Take Care With Meds That Should Be Given Together
Migraine Stay Alert for "As Directed" Sigs on Nurtec ODT Rxs
Alzheimer's Disease Listen for Questions About Aduhelm for Alzheimer's Disease
Infectious Diseases Prevent Mishaps When Dispensing Meds for C. diff Diarrhea
Topicals Help Patients Asking About Water Exposure and Topical or Transdermal Meds
Communication Don't Shy Away From Communicating Concerns to Colleagues
Rheumatoid Arthritis Avoid Mix-Ups With Rheumatoid Arthritis Meds